Clinical Trials on Primary Peritoneal Cancer in Austria

Total 4067 results

Dr. Anton Hommer

Completed

An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More

Primary Open Angle Glaucoma | Ocular Hypertension

Austria
Eli Lilly and Company

Completed

An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy

Genital Neoplasms, Female | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Pelvic Neoplasms

United States, Puerto Rico
Merck Sharp & Dohme LLC
Gynecologic Oncology Group; European Network of Gynaecological Oncological...

Active, not recruiting

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer

Poland, Korea, Republic of, United States, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
iOMEDICO AG
Seagen Inc.

Recruiting

Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens. (TRACE)

HER2-positive Breast Cancer

Germany, Austria
Austrian Urogynecology Working Group (AUWG)

Completed

Retropubic vs. Transobturator Tension-free Vaginal Tape

Stress Urinary Incontinence

Austria
Medical University of Vienna

Recruiting

p53 and Response to Preoperative Radiotherapy for T2 and T3 (PART1)

Rectal Cancer

Austria
zr Pharma & GmbH
Foundation Medicine; Myriad Genetics, Inc.

Completed

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) (ARIEL3)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States, Spain, Belgium, Australia, Israel, Germany, France, United Kingdom, Italy, Canada, New Zealand
Peter MacCallum Cancer Centre, Australia

Recruiting

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancer (AlphaBet)

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
Bristol-Myers Squibb

Recruiting

A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib

Myelofibrosis

Austria
Medical University of Vienna

Completed

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length

Menorrhagia

Austria
Aulos Bioscience, Inc.

Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Metastatic Cancer | Advanced Solid Tumor

Australia, United States
Medical University of Graz

Recruiting

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Carcinoma (SOUND)

Metastatic Cancer | Locally Advanced Carcinoma

Austria
Barwon Health

Terminated

A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment (PROFUGO)

Prostate Cancer

Australia
Arduino Mangoni

Completed

Mechanisms of Anti-VEGF Induced Hypertension

Renal Cancer

Australia
Prim. Priv. Doz. Dr. Daniel Cejka
Vifor Fresenius Medical Care Renal Pharma

Completed

The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum

Endstage Renal Disease

Austria
University of Vienna

Unknown

Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB) (MIKRODIAB)

Cancer | Type 2 Diabetes

Austria
Queensland Centre for Gynaecological Cancer

Completed

Telephone Follow-up After Treatment for Endometrial Cancer (TEACUP)

Endometrial Cancer

Australia
Queensland Centre for Gynaecological Cancer
The University of Queensland; Greenslopes Private Hospital; Sullivan and Nicolaides...

Completed

The Effects of the Endocrine System on Endometrial Cancer (Ghrelin)

Endometrial Cancer

Australia
PharmAbcine
Merck Sharp & Dohme LLC

Recruiting

Olinvacimab With Pembrolizumab in Patients With mTNBC

Metastatic Triple-Negative Breast Cancer

Australia
Karl Landsteiner Institute for Lung Research and...

Completed

Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"

Lung Cancer

Austria
Pfizer

Terminated

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Low-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal Cancer

United States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
Medical University of Vienna

Completed

Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity (LUDOC II)

Ovarian Epithelial Cancer

Austria, Belgium, Czechia, Germany
Mologen AG

Completed

Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC (IMPULSE)

Small Cell Lung Cancer

Belgium, Spain, Austria, Germany
Peter MacCallum Cancer Centre, Australia
United States Department of Defense; Advanced Accelerator Applications; Australian... and other collaborators

Active, not recruiting

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy (UpFrontPSMA)

Metastatic Hormone Naive Prostate Cancer

Australia
Association of Research on the Biology of Liver...

Completed

Cetuximab + Gemox in Biliary Tract Cancer

Metastatic | Locally Advanced | Unresectable

Austria
Angle plc
Medical University of Vienna; Charite University, Berlin, Germany; Vivantes Netzwerk...

Completed

Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.

Ovarian Neoplasms

Germany, Austria
Nucletron Operations BV
Factory CRO

Completed

Post Market Clinical Follow-up Study Venezia

Cervical Cancer

Austria, Netherlands, Germany
Fusion Pharmaceuticals Inc.

Terminated

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Breast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Liver Cancer | Bladder Carcinoma | Susceptible FGFR3 Genetic Alterations | FGFR3 | FGFR3 Overexpression | FGFR3 Receptor | FGFR3 Protein Overexpression

United States, Australia
Medical University Innsbruck

Completed

Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy

Alopecia | Breast Cancer Female

Austria
Medical University of Vienna

Completed

An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects

Glaucoma | Macular Degeneration | Regional Blood Flow

Austria
Medical University of Vienna

Completed

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

Pneumonia | Urinary Tract Infection | Abdominal Infection

Austria
Quadriga Biosciences, Inc.
Novotech (Australia) Pty Limited

Completed

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Melanoma | Sarcoma | Kidney Cancer | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Astrocytoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Thymic Carcinoma | Lung Cancer | Prostate Cancer | Brain Cancer | Cholangiocarcinoma | Bladder Cancer | Liver Cancer | Brain Metastases | Tongue Cancer | Esophagus... and other conditions

Australia
Medical University of Vienna

Unknown

Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection

Gd-based Contrast Media Exposure During Breast MRI Scans

Austria
Medical University of Vienna

Completed

Clinical Experience With Numeta in Preterm Infants (Numeta)

Premature Infants

Austria
Medical University of Vienna

Suspended

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Sterility

Austria
Prof. Dr. Matthias Preusser

Unknown

Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)

Primary Central Nervous System Lymphoma

Austria
The Ludwig Boltzmann Institute of Retinology and...

Completed

Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment

Rhegmatogenous Retinal Detachment | Primary Vitrectomy | Encircling Band | Endolaser Treatment

Austria
Medical University of Vienna

Completed

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Physiology | Retina

Austria
German Breast Group

Recruiting

Long-term Safety and Efficacy of GBG Study Participants (ETERNITY)

Breast Cancer

Austria
University of Sydney
Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaborators

Completed

Evaluation of a Patient-Reported Symptom Index for NMIBC

Superficial Bladder Cancer

United States, Australia, New Zealand, Canada, United Kingdom
Medical University of Graz

Recruiting

IUL Study A Randomized Sham - Controlled Clinical Study

Stress Urinary Incontinence

Austria
OncoResponse, Inc.

Recruiting

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer | Metastatic Cancer | Advanced Solid Tumor | Platinum-resistant Ovarian Cancer | Malignant Neoplasm | Tumor, Solid | Cutaneous Squamous Cell Carcinoma

United States
Ferronova Pty Ltd
Austin Health; Peter MacCallum Cancer Centre, Australia; Flinders Medical Centre and other collaborators

Recruiting

Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation (MAGMAP)

Gastric Cancer | Esophageal Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health; M.D. Anderson Cancer Center; The Alfred

Completed

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study (VAPOR-C)

Cancer, Breast | Cancer Colorectal | Cancer, Lung | Cancer Prostate | Cancer Melanoma Skin | Cancer, Other

Australia
Hoffmann-La Roche

Terminated

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (LISAH)

Breast Cancer

Austria
Royal North Shore Hospital

Recruiting

3D Printed Custom Applicators for HDR BT (DISCO)

Gynecologic Cancer | Endometrial Cancer | Vaginal Cancer | Vulva Cancer

Australia
ProteoMediX AG

Completed

PRospective Prostate biOmarker Study (PROPOSe)

Indication for Prostate Biopsy Due to Suspected Prostate Cancer

Austria, Germany, Denmark
Prim. Priv. Doz. Dr. Daniel Cejka
Amgen

Completed

A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients

End Stage Renal Disease

Austria
Univ.-Doz. Dr.med.univ. Gernot Hudelist, MSc.

Completed

Comparison of Ultrasound-determined and Intraoperative #Enzian-classification in Patients With Deep Endometriosis

Endometriosis

Austria
Janux Therapeutics

Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | Castration Resistant Prostatic Cancer

United States, Australia

Clinical Trials on Primary Peritoneal Cancer in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations